Dr. Julian J. Lum obtained his PhD in Immunology from the University of Ottawa. His lab at Deeley Research Centre at BC Cancer focuses on identifying metabolic targets for cell-based immunotherapy, where Dr. Lum’s core approach is to metabolically engineer CAR T cells using CRISPR-Cas-based gene-editing to overcome metabolic barriers in the tumor microenvironment.